Last reviewed · How we verify

NCT05198999

Aquatic-based Explosive Strength Training in Children With Cerebral Palsy

Completed NA Last updated 20 January 2022
What this trial tests

NA trial testing Aquatic-based Plyometric Exercises in Cerebral Palsy in 56 participants. Completed in 26 September 2019.

Timeline
6 August 2018
Primary endpoint
26 September 2019
26 September 2019

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment56
Start date6 August 2018
Primary completion26 September 2019
Estimated completion26 September 2019
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 12 to 16, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was designed to assess the effect of a 12-week aquatic-based plyometric (Aqua-PLYO) training on postural control and functional performance in children with hemiparetic cerebral palsy (h-CP). Fifty-six children with h-CP were randomly allocated to the Aqua-PLYO group (n = 28, received an Aqua-PLYO training program, trice/week, over 12 weeks) or the control group (n =28, received standard rehabilitation). Both groups were assessed for postural control and functional performance pre and post-treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05198999.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing